Macrogenics (MGNX) Share-based Compensation (2012 - 2026)

Macrogenics (MGNX) has 15 years of Share-based Compensation data on file, last reported at $2.6 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $2.6 million, down 39.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.5 million (down 55.62% YoY), and the FY2025 annual result was $14.3 million, down 51.47% from the prior year.
• Share-based Compensation fell to $2.6 million in Q1 2026 per MGNX's latest filing, from $2.7 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $11.3 million in Q4 2024 and troughed at $2.6 million in Q1 2026.
• A 5-year average of $5.0 million and a median of $4.8 million in 2023 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation jumped 158.43% in 2024, then plunged 76.38% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $4.7 million in 2022, then declined by 8.06% to $4.4 million in 2023, then soared by 158.43% to $11.3 million in 2024, then sank by 76.38% to $2.7 million in 2025, then declined by 0.56% to $2.6 million in 2026.
• Business Quant data shows MGNX's Share-based Compensation at $2.6 million in Q1 2026, $2.7 million in Q4 2025, and $3.5 million in Q3 2025.